Data / Form D filings / Tvardi Therapeutics, Inc.
Tvardi Therapeutics, Inc.: Form D filings
Tvardi Therapeutics, Inc., a biotechnology company in Houston, TX, filed 3 Form D notices with the SEC between 2018 and 2021. The latest, on June 16, 2021, reports $72.4 million sold of a $75.1 million offering to 32 investors.
Find out what Tvardi Therapeutics, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2450 Holcombe Boulevard, Suite X, Houston, TX, 77021
- Phone
- (832) 413-1362
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2017
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1742947
The full lists. Form D filings in Texas: 4,800 rows, $128, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 16, 2021 | New notice | $75,058,256 | $72,418,254 | $2,640,002 | 32 | Jun 3, 2021 | sec.gov |
| Jul 30, 2018 | Amendment | $8,500,000 | $5,649,659 | $2,850,341 | 8 | Jun 4, 2018 | sec.gov |
| Jun 8, 2018 | New notice | $5,000,000 | $3,149,658 | $1,850,342 | 6 | Jun 4, 2018 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Jamie McNab | Director | |
| Michael Wyzga | Director | |
| Wallace Hall | Director | |
| Imran Alibhai | Executive Officer, Director | |
| Sujal Shah | Director |
Other biotechnology companies in Texas that filed recently
- Nuclein, LLC $15.7 million · Oct 27, 2026
- OncoNano Medicine, Inc. $10.1 million · Oct 8, 2026
- Solaris Endovascular Inc. $5 million · Oct 1, 2026
- Hera Biotech, Inc. $1.7 million · Sep 23, 2026
- Kayak Therapeutics, Inc. $25 million · Aug 21, 2026
- InnovoTEX Inc. $2.7 million · Aug 18, 2026
Every Form D from the week of Jun 14, 2021 · All recent filings in Texas · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Tvardi Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.